WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014177585) BIOCATALYTIC PRODUCTION OF NUCLEOSIDE ANALOGUES AS ACTIVE PHARMACEUTICAL INGREDIENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/177585    International Application No.:    PCT/EP2014/058761
Publication Date: 06.11.2014 International Filing Date: 29.04.2014
Chapter 2 Demand Filed:    16.02.2015    
IPC:
C12P 19/40 (2006.01), C12N 9/10 (2006.01)
Applicants: PLASMIA BIOTECH, S.L [ES/ES]; C/ Temple, 15-19 1º 1ª Badalona E-08911 Barcelona (ES)
Inventors: PASCUAL GILABERT, Marta; (ES).
DERONCELÉ THOMAS, Victor Manuel; (ES).
MONTILLA ARÉVALO, Rafael; (ES)
Agent: ILLESCAS TABOADA, Manuel; C/ Príncipe de Vergara, 197, Oficina 1º A E-28002 Madrid (ES)
Priority Data:
61/817,064 29.04.2013 US
Title (EN) BIOCATALYTIC PRODUCTION OF NUCLEOSIDE ANALOGUES AS ACTIVE PHARMACEUTICAL INGREDIENTS
(FR) PRODUCTION BIOCATALYTIQUE D'ANALOGUES NUCLÉOSIDIQUES EN TANT QUE PRINCIPES ACTIFS PHARMACEUTIQUES
Abstract: front page image
(EN)A biocatalytic process for producing active pharmaceutical ingredients (APIs) or intermediates thereof, wherein those APIs or their intermediates are nucleoside analogues (NAs) of formula (I), and wherein said NAs are active as pharmaceutically relevant antivirals and anticancer medicaments, intermediates or prodrugs thereof using nucleoside deoxyribosyltransferase from Lactobacillus.
(FR)L'invention porte sur un procédé biocatalytique de production de principes actifs pharmaceutiques (API) ou d'intermédiaires de ces derniers. Ces API ou leurs intermédiaires sont des analogues nucléosidiques (NA) de formule (I), et lesdits NA sont actifs en tant que médicaments antiviraux et anticancéreux appropriés au plan pharmaceutique, intermédiaires ou promédicaments de ces derniers. FIG. 0:
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)